+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Saudi Arabia Veterinary Pharmaceuticals Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 110 Pages
  • December 2024
  • Region: Saudi Arabia
  • Knowledge Sourcing Intelligence LLP
  • ID: 5682066
The Saudi Arabia Veterinary Pharmaceuticals market is expected to grow at a compound annual growth rate (CAGR) of 6.66% from US$36.544 million in 2025 to US$50.451 million in 2030.

The field of medical science that focuses on the diagnosis, treatment, prevention, and general healthcare of animals is known as veterinary medicine or just vet medicine. It includes a broad spectrum of medical procedures and offerings aimed at guaranteeing the health and welfare of animals, both tamed and wild. Veterinarians offer animals complete medical care, including vaccinations, surgeries, dental care, and specialized treatments in addition to routine checkups. Their objective is to preserve and enhance the well-being and standard of living of animals. An essential component of veterinary pharmaceuticals is preventive care. It comprises preventative measures to avoid illness and guarantee the long-term health of animals, such as vaccinations, parasite control, wellness examinations, and dietary advice.

A range of diagnostic techniques, such as physical examinations, blood tests, imaging, and laboratory testing, are employed by veterinarians to detect and manage medical conditions in animals. Surgical procedures performed by veterinarians range from simple spaying and neutering to intricate operations to treat congenital conditions, remove tumors, and treat injuries. In veterinary medicine, surgical procedures are similar to those in human medicine.

Moreover, the need for animal production is also being fueled by Saudi Arabia's increasing demand for dairy and meat due to the country's increased need for protein and animal-based products. For instance, according to the Foreign Agricultural Service. Saudi Arabia is promoting the growth of poultry farming in the country. The Ministry of Environment, Water, and Agriculture announced the issuance of new licenses in the poultry production and breeding sector in the Kingdom, amounting to 275 new licenses. 119 licenses for broiler projects 26 new projects to produce eggs with a production capacity of more than two billion eggs per year, and 12 projects to breed and produce broiler mothers and operate hatcheries. The demand for veterinary vaccines to maintain good veterinary health in Saudi Arabia is being further driven by the trend toward increased animal consumption and production indicators and an overall increase in the demand for agricultural livestock.

Further, pets are becoming more and more important in Saudi Arabian households, which has increased demand for veterinary care and pet supplies like food, medicine, and vaccinations. Animal health, including vaccinations and disease control strategies, is receiving more attention as a result of worries about zoonotic diseases, or illnesses that can spread from animals to people. Improvements in veterinary medicine, including better medications, diagnostic equipment, and therapeutic techniques, have broadened the selection of goods and services available, propelling market expansion. The market has grown as a result of growing awareness among veterinarians, livestock farmers, and pet owners of the value of preventive care and veterinary care. For instance, in April 2022, ADQ and E20 Investment Ltd. collaborated to launch a novel animal health platform in Abu Dhabi, signifying a noteworthy achievement for the country's animal healthcare industry. The medical platform is built around two state-of-the-art veterinary clinics and a state-of-the-art vaccine production facility. The facilities offer the most cutting-edge technological animal vaccinations for the Middle East and Africa (MEA) region, further solidifying Abu Dhabi's position as a regional superpower in the field of upscale veterinary care for horses and camels.

Further, the market is also anticipated to be driven during the forecast period by an increase in the number of veterinary hospitals and clinics in Saudi Arabia. The market for veterinary care has been significantly impacted by the rise in pet ownership in Saudi Arabia. As a result, the need for veterinary clinics in the area has increased. It is also expected that the market will expand due to the rise in veterinary pharmacies. Furthermore, it is anticipated that rising sales of over-the-counter medications and other goods will offer lucrative opportunities for industry players. For instance, Saudi Arabia's Qassim Gov. Prince Faisal bin Mishaal opened the largest camel hospital in the world in July 2022. Saudi Arabia's veterinary hospitals strive to treat animals as best they can by utilizing a variety of techniques and technological advancements. The market is anticipated to grow as a result of ongoing improvements to the services and facilities offered, such as central laboratories equipped with contemporary equipment.

Saudi Arabia veterinary pharmaceuticals market drivers

Rising pet ownership is projected to propel the Saudi Arabia veterinary pharmaceuticals market expansion.

There is a significant increase and growth in the pet industry in Saudi Arabia and its related sectors, such as food, grooming tools, accessories, and veterinary equipment. The key driver behind the growth of the pet products market in Saudi Arabia is the rising disposable income among households. With higher incomes, pet owners are more willing to spend on multiple products for their pets including healthcare.

This massive shift in the pet market has led to an expansion of product offerings in the market, with the healthcare and wellness segment of the Saudi Arabia pet products market also witnessing a rise, as pet owners are becoming aware of their pets' health and seek out preventive and curative healthcare products, such as supplements, vitamins, and specialized treatments.

Several other factors such as the increasing number of veterinary clinics. There are 434 clinics, and the number of specialized veterinary pharmacies is 1,366, specializing in meeting the needs in 2023. Further, the availability of pet insurance and veterinary services has also caused a surge in the overall market.

Reasons for buying this report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Saudi Arabia veterinary pharmaceuticals market is analyzed into the following segments:

By Type

  • Injectable
  • Oral
  • Topical
  • Auricular, Ophthalmic, and Nasal

By Animal Type

  • Companion Animal
  • Production Animal

By End User

  • Vet Hospitals and Clinics
  • Animal Farms
  • Others

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY TYPE
5.1. Introduction
5.2. Injectable
5.3. Oral
5.4. Topical
5.5. Auricular, Ophthalmic, and Nasal
6. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY ANIMAL TYPE
6.1. Introduction
6.2. Companion Animal
6.3. Production Animal
7. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY END USER
7.1. Introduction
7.2. Vet Hospitals and Clinics
7.3. Animal Farms
7.4. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Montajat Veterinary Pharmaceuticals Co., Ltd.
9.2. Vetoquinol
9.3. Saudi Pharmaceutical Industries SPI
9.4. Pharma Care Leading Manufacturing Co. Ltd.
9.5. Salehiya Healthcare
9.6. Merck & Co.
9.7. Bayer AG
9.8. Sanofi
9.9. Pfizer Inc
9.10. GSK plc
9.11. Boehringer Ingelheim International GmbH
9.12. Takeda Pharmaceutical Company Limited

Companies Mentioned

  • Montajat Veterinary Pharmaceuticals Co., Ltd.
  • Vetoquinol
  • Saudi Pharmaceutical Industries SPI
  • Pharma Care Leading Manufacturing Co. Ltd.
  • Salehiya Healthcare
  • Merck & Co.
  • Bayer AG
  • Sanofi
  • Pfizer Inc
  • GSK plc
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information